Enhancing the Therapeutic Efficacy of Gefitinib in Human Non-Small-Cell Lung Cancer through Drug Combination-Reference-Cited by-同舟云学术

Enhancing the Therapeutic Efficacy of Gefitinib in Human Non-Small-Cell Lung Cancer through Drug Combination

Published:2021-01-20 Issue:3 Volume:18 Page:1397-1407
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Zhang Mengran¹,Cai Hao¹,Du Yue¹²,Wang Yuexuan¹,Gong Jianhua¹,Xu Jian¹^ORCID,Liu Xiujun¹

Affiliation:

1. Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Tiantanxili, Beijing 100050, China

2. Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China

Funder

Ministry of Science and Technology of the People's Republic of China

Chinese Academy of Medical Sciences

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c01203

Reference38 articles.

1. Lung Cancer Prevention

2. AJRCCM: 100-YearAnniversary.The Shifting Landscape for Lung Cancer: Past, Present, and Future

3. Lung cancer

4. Lung cancer: needs assessment, treatment and therapies

5. Targeted drugs for systemic therapy of lung cancer with brain metastases

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three Polymorphs and Two Hydrates of a Multidrug Crystal Involving Gefitinib and Rhein: Characterization, Stability, and Solubility Aspects;Crystal Growth & Design;2024-05-13

2. CD13 expression affects glioma patient survival and influences key functions of human glioblastoma cell lines in vitro;BMC Cancer;2024-03-22

3. Reviving Intervertebral Discs: Treating Degeneration Using Advanced Delivery Systems;Molecular Pharmaceutics;2024-01-22

4. A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and In Silico Verification;Evidence-Based Complementary and Alternative Medicine;2023-01-09

5. “Drug–Coformer–Drug” Multicomponent Crystals to Simultaneously Improve the Solubility of Two Insoluble Combined Drugs by Introduction of a Soluble Coformer;Crystal Growth & Design;2022-09-06